FBTCX Mutual Fund

NAV$29.44

Returns Overview

1 Month
+2.10%
3 Months
-1.08%
6 Months
+31.50%
YTD
+4.25%
1 Year
+43.53%
3 Years
+19.25%
5 Years
+11.36%
10 Years
+15.96%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FBTCX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

No data

3 Months Performance

No data

6 Months Performance

No data

1 Year Performance

No data

Benchmark & Peers

Benchmark
MSCI USA IMI Biotechnology 25/50 Index(^MSUIMBTC2550)
This Mutual Fund (YTD)
+4.25%
Peer Avg (YTD)
+1.55%
vs Peers
+2.70%

FBTCX Mutual Fund Performance

FBTCX performance across multiple time periods: 1-month 2.10%, YTD 4.25%, 1-year 43.53%, 3-year 19.25%, 5-year 11.36%, 10-year 15.96%.

FBTCX returns outperform the peer average of 1.55% YTD. With an expense ratio of 1.71%, investors should weigh costs against performance when evaluating this mutual fund.

FBTCX performance comparison shows side-by-side returns with another fund. FBTCX alternatives are available in the Mutual Fund Screener.